Quick Takeaways
- FRANKLIN RESOURCES INC filed SCHEDULE 13G/A for Contineum Therapeutics, Inc. Class A Common Stock, $0.001 par value per share (CTNM).
- Disclosed ownership: 6.2%.
- Date of event: 31 Dec 2025.
Quoteable Key Fact
"FRANKLIN RESOURCES INC disclosed 6.2% ownership in Contineum Therapeutics, Inc. Class A Common Stock, $0.001 par value per share (CTNM) on 31 Dec 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Franklin Resources, Inc. | 6.2% | 1,879,367 | 1,879,367 | 0 | /s/Thomas C. Mandia | Thomas C. Mandia, Assistant Secretary of Franklin Resources, Inc. | |
| Charles B. Johnson | 0% | 0 | 0 | 0 | /s/Thomas C. Mandia | Attorney in Fact for Charles B. Johnson pursuant to Power of Attorney | |
| Rupert H. Johnson, Jr. | 0% | 0 | 0 | 0 | /s/Thomas C. Mandia | Attorney in Fact for Rupert H. Johnson, Jr. pursuant to Power of Attorney | |
| Franklin Advisers, Inc. | 6.2% | 1,879,367 | 1,879,367 | 0 | /s/Thomas C. Mandia | Thomas C. Mandia, Assistant Secretary of Franklin Advisers, Inc. |